Your browser doesn't support javascript.
loading
Comparison of diglycolic acid exposure to human proximal tubule cells in vitro and rat kidneys in vivo.
Mossoba, Miriam E; Vohra, Sanah; Toomer, Howard; Pugh-Bishop, Shelia; Keltner, Zachary; Topping, Vanessa; Black, Thomas; Olejnik, Nicholas; Depina, Ana; Belgrave, Kathleen; Sprando, Jessica; Njorge, Joyce; Flynn, Thomas J; Wiesenfeld, Paddy L; Sprando, Robert L.
Afiliação
  • Mossoba ME; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Vohra S; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Toomer H; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Pugh-Bishop S; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Keltner Z; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Topping V; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Black T; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Olejnik N; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Depina A; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Belgrave K; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Sprando J; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Njorge J; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Flynn TJ; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Wiesenfeld PL; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
  • Sprando RL; U.S. Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Applied Research and Safety Assessment (OARSA), Division of Toxicology (DOT), 8301 Muirkirk Rd., Laurel, MD 20708, United States.
Toxicol Rep ; 4: 342-347, 2017.
Article em En | MEDLINE | ID: mdl-28959658
ABSTRACT
Diglycolic acid (DGA) is present in trace amounts in our food supply and is classified as an indirect food additive linked with the primary GRAS food additive carboxymethyl cellulose (CMC). Carboxymethyl starches are used as a filler/binder excipient in dietary supplement tablets and a thickening ingredient in many other processed foods. We sought to utilize the human proximal tubule HK-2 cell line as an in vitro cellular model system to evaluate its acute nephrotoxicity of DGA. We found that DGA was indeed toxic to HK-2 cells in all in vitro assays in our study, including a highly sensitive Luminex assay that measures levels of an in vitro biomarker of kidney-specific toxicity, Kidney Injury Molecule 1 (KIM-1). Interestingly, in vitro KIM-1 levels also correlated with in vivo KIM-1 levels in urine collected from rats treated with DGA by daily oral gavage. The use of in vitro and in vivo models towards understanding the effectiveness of an established in vitro system to predict in vivo outcomes would be particularly useful in rapidly screening compounds that are suspected to be unsafe to consumers. The merit of the HK-2 cell model in predicting human toxicity and accelerating the process of food toxicant screening would be especially important for regulatory purposes. Overall, our study not only revealed the value of HK-2 in vitro cell model for nephrotoxicity evaluation, but also uncovered some of the mechanistic aspects of the human proximal tubule injury that DGA may cause.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article